Mesoblast
Price & Volume
Stats
See more52W Range | $13.05-$21.50 |
Market Cap | $1.7B |
Shares Short | 3M |
Financials
See moreRevenue (12 Mos) | $120.2M |
Revenue Growth (YoY) | 390.7% |
Gross Profit (12 Mos) | $96.2M |
Diluted EPS | -$0.44 |
News
See moreYahoo Finance • 10 days ago
Cochlear And 2 Australian Healthcare Stocks To Watch
Yahoo Finance • 2 months ago
Mesoblast Reports Ryoncil® Net Revenues of US$36M for the Quarter and US$115M for First Full Year of Product Launch
Yahoo Finance • 3 months ago
Mesoblast Achieves Target of 300 Treated Patients in Pivotal Phase 3 Trial for Chronic Low Back Pain
About
CEO | Dr. Silviu Itescu FACP, FACRA, FRACP, MBBS (Hons) |
Address | 55 Collins Street, Melbourne, VIC, Australia, 3000 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 108 |